Specifically, CCL2, CCL3, CCL4, CXCL8, and CXCL10 levels are also increased in the peripheral blood of patients with IIM (28, 32, 33), suggesting their role in the systemic inflammatory response simultaneously. This evidence concerns the gene CXCL10 and acquired idiopathic inflammatory myopathy.